Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Neelapu SS 

PROVIDER: S-EPMC7273828 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature